Shares of biotech Sarepta soar 40% after approval for most expensive treatment in the world
Shares in cancer-test developer trading in low volumes ahead of spin-off demanded by antitrust regulators
Avid Bioservices made a blunder
Critics of plan include green activists, farmers, biotech start-ups and multinationals
Innovation prize targeting urinary tract infections boosts effort to tackle pathogens that develop immunity to drugs
Alcohol, food, tobacco and fossil fuel sectors oppose efforts to target conditions linked to 2.7mn deaths a year, warns WHO
A new WHO survey suggests that they are more exposed than men to superbugs
Health authorities move to protect farmworkers and other high-risk groups after recent outbreaks
Independent experts conclude unanimously that the experimental treatment is effective
Vaccine maker to seek approval for jab as it tries to diversify product pipeline
Pharma group believes successful medicines from its clinical trials could generate $20bn in revenue by 2030
Two developers of drugs for inflammatory diseases are latest to disregard poor performance of newly listed companies
Launch highlights growth of venture philanthropy to boost search for treatments and cures
As incidence rises, breakthroughs in oncology show the value of research funding
Both OZEM and THNR offer very concentrated bets on a fast-moving market
Brent Wisner, who won billions of dollars against Bayer, has received a big boost in Zantac cancer case
Non-binding vote on psychedelic drug will carry weight with FDA in blow to pharmaceutical developers
Litigation over Zantac is only one of several doubts the UK pharma group needs to overcome
Ruling means plaintiffs can present evidence alleging link between heartburn drug and cancer
The deal is expected to be one of Europe’s largest this year as EU IPO market shows signs of recovery
Judge rules experts’ evidence admissible, leaving route open for 72,000 cancer sufferers to bring cases
US decision hands biotech group its first regulatory blessing since its blockbuster Covid-19 jab
Funding would help to bolster stockpile as CDC reports third dairy worker infected
People with cystic fibrosis, epilepsy and diabetes among those struggling with medicine shortages
US group hopes EyeBio will refill its pipeline with treatments targeting causes of blindness
UK Edition
